Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 71% ± 21% | |
| GABAergic neuron | 10 studies | 66% ± 25% | |
| glutamatergic neuron | 10 studies | 81% ± 16% | |
| microglial cell | 8 studies | 35% ± 18% | |
| endothelial cell | 7 studies | 47% ± 19% | |
| interneuron | 6 studies | 64% ± 22% | |
| retinal ganglion cell | 6 studies | 72% ± 27% | |
| neuron | 5 studies | 49% ± 20% | |
| astrocyte | 5 studies | 40% ± 23% | |
| amacrine cell | 5 studies | 49% ± 22% | |
| retina horizontal cell | 4 studies | 41% ± 21% | |
| oligodendrocyte | 4 studies | 39% ± 26% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 59% ± 10% | |
| GABAergic interneuron | 3 studies | 73% ± 12% | |
| GABAergic amacrine cell | 3 studies | 82% ± 11% | |
| OFF-bipolar cell | 3 studies | 65% ± 15% | |
| ON-bipolar cell | 3 studies | 66% ± 11% | |
| glycinergic amacrine cell | 3 studies | 48% ± 17% | |
| rod bipolar cell | 3 studies | 68% ± 33% | |
| smooth muscle cell | 3 studies | 37% ± 13% | |
| fibroblast | 3 studies | 38% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 2398.81 | 2399 / 2642 | 96% | 13.63 | 675 / 705 |
| adrenal gland | 100% | 2319.13 | 258 / 258 | 84% | 10.15 | 193 / 230 |
| prostate | 85% | 714.66 | 209 / 245 | 46% | 1.20 | 232 / 502 |
| ovary | 96% | 2182.37 | 173 / 180 | 17% | 0.47 | 75 / 430 |
| uterus | 87% | 1412.28 | 148 / 170 | 16% | 0.76 | 75 / 459 |
| kidney | 61% | 393.24 | 54 / 89 | 34% | 1.28 | 308 / 901 |
| intestine | 61% | 471.74 | 585 / 966 | 4% | 0.09 | 20 / 527 |
| blood vessel | 64% | 1023.62 | 858 / 1335 | 0% | 0 | 0 / 0 |
| breast | 22% | 128.59 | 99 / 459 | 40% | 3.78 | 450 / 1118 |
| skin | 0% | 0.97 | 6 / 1809 | 48% | 1.61 | 228 / 472 |
| muscle | 47% | 250.67 | 376 / 803 | 0% | 0 | 0 / 0 |
| bladder | 38% | 107.57 | 8 / 21 | 5% | 0.27 | 27 / 504 |
| esophagus | 23% | 72.25 | 330 / 1445 | 19% | 0.48 | 34 / 183 |
| pancreas | 9% | 24.33 | 31 / 328 | 28% | 0.99 | 49 / 178 |
| eye | 0% | 0 | 0 / 0 | 36% | 0.76 | 29 / 80 |
| thymus | 14% | 43.89 | 92 / 653 | 21% | 1.34 | 129 / 605 |
| liver | 10% | 25.94 | 22 / 226 | 21% | 0.71 | 84 / 406 |
| lung | 0% | 0.99 | 2 / 578 | 17% | 0.66 | 202 / 1155 |
| stomach | 10% | 31.39 | 36 / 359 | 6% | 0.16 | 17 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.53 | 7 / 45 |
| adipose | 13% | 48.66 | 162 / 1204 | 0% | 0 | 0 / 0 |
| heart | 11% | 34.10 | 93 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.21 | 3 / 29 |
| peripheral blood | 2% | 9.32 | 22 / 929 | 0% | 0 | 0 / 0 |
| spleen | 0% | 1.08 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0016020 | Cellular component | membrane |
| GO_0005112 | Molecular function | Notch binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| Gene name | ATRNL1 |
| Protein name | ATRNL1 protein Attractin-like protein 1 Attractin like 1 |
| Synonyms | KIAA0534 |
| Description | FUNCTION: May play a role in melanocortin signaling pathways that regulate energy homeostasis. . |
| Accessions | ENST00000527407.5 A0A087X0X7 Q4G0Y2 ENST00000650603.1 Q5VV63 ENST00000609571.5 [Q5VV63-2] ENST00000355044.8 [Q5VV63-1] A0A3B3ISV6 ENST00000616894.1 R4GMZ1 ENST00000526946.5 E9PL90 ENST00000526373.1 H0YDQ9 |